Insurers eye life sciences in Asia as rates rise
April 28 2022 by Nick Ferguson
-
Suncorp’s Vero Insurance expands into specialty lines
- November 8
The first product to be launched will be high hazard property, which will focus more on businesses with more complex risk profiles rather than those exposed to higher natural hazard losses.
-
Liberty Mutual names APAC head of claims for international insurance business amid regional leadership reshuffle
- November 4
The carrier has expanded its recently formed commercial and specialty (re)insurance team with the appointment of Robert Mercer, who is succeeding Carlos Alberto Martinez who will retire by the end of the year.
-
Canopius’ APAC expansion builds around specialty lines demand
- November 1
The priority for Canopius is to maintain disciplined growth in the specialty lines where it has a differentiated offering, like energy, marine, agriculture treaty, and structured credit, says regional chief executive SK Lee.
-
Specialty growth, Australia, Dubai operations fire up Markel’s APAC growth
- November 1
The Lloyd’s player, set to grow premiums by 40% in 2024, is seeing strong demand for the war, renewable energy, and casualty classes in the region, says Christian Stobbs.
-
BHSI | Managing non-Asian exposure in long-tail lines
While US-exposed business can look attractive to Asian carriers, managing the volatility around the long-term results and the ability to model those losses are crucial, say BHSI’s Marc Breuil and Marcus Portbury.
-
Sedgwick | To Handle CAT Claims Well, Multi-Step Preparation is Key
When it comes to risk, it’s not a matter of “if” it’s a matter of “when” an event will occur.
-
HSBC Asset Management | Is it time to relook at Asian currency bonds?
With diversification and performance high on investors’ agendas, it seems a good time for global portfolios to revive allocations in Asian local currency bonds – including Hong Kong dollar (HKD) bonds.
-
PineBridge Investments | Why Asian insurers are exploring private credit and CLOs
The recent rollout of risk-based capital regimes across Asia calls for a closer alignment between insurers’ assets and liabilities. We explore potential ways to maintain a healthy investment yield and robust returns on regulatory capital.
